Ponesimod for the treatment of relapsing multiple sclerosis
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1799977
Abstract: ABSTRACT Introduction Multiple Sclerosis (MS) is an immune-mediated, complex, chronic inflammatory, and neurodegenerative disease of the central nervous system. Among the several therapeutic options developed over the last decade for relapsing MS (RMS), fingolimod, a… read more here.
Keywords: multiple sclerosis; ponesimod; ponesimod treatment; treatment relapsing ... See more keywords